Tom Vanormelingen

Head of Market Access & Public Affairs Sandoz

Pharma Launch Excellence Summit Main Conference Day 1: Wednesday 2nd December

4:30 PM Case Study Presentation: Preparing for the Golden Decade of Biosimilars: Policy Shaping to Drive Biosimilar Uptake from 33% to 66% in The Belgian Market

Biosimilars are entering the Golden Decade, yet uptake remains uneven across healthcare systems, limiting both patient access and healthcare sustainability.

Achieving launch excellence requires more than a successful product launch, it demands policy shaping, stakeholder alignment and a supportive adoption

environment. This session explores how Belgium is developing a national policy roadmap to accelerate biosimilar uptake from 33% to 66%. Through a real-world use case on designing and implementing a multi-stakeholder biosimilar policy initiative, attendees will learn how to identify structural barriers, engage key decision-makers and build the conditions for sustainable adoption. The session will also share early insights and lessons learned following the public launch of the initiative.

• Identifying the structural and policy barriers limiting biosimilar uptake

• Learning how to align policymakers, healthcare professionals and industry stakeholders around a shared vision

• Discovering practical steps to shape the policy environment needed for sustainable biosimilar adoption

• Exploring a real-world use case on building a national biosimilar policy roadmap to accelerate uptake and improve patient access

Check out the incredible speaker line-up to see who will be joining Tom.

Download The Latest Agenda

In Partnership With:

QUESTIONS?

Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: 44 (0) 207 368 9300
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk